<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03454594</url>
  </required_header>
  <id_info>
    <org_study_id>P.T.REC/012/001561</org_study_id>
    <nct_id>NCT03454594</nct_id>
  </id_info>
  <brief_title>Watch Laser Acupuncture With Nasal Radiation for Prevention of Coronary Artery Disease</brief_title>
  <official_title>Laser Hemotherapy Trial for Coronary Artery Disease Prevention in High Risk Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effect of low level laser blood radiation applied to all
      participants for prevention of coronary artery disease in patients with high risk
      (hypertension,high blood viscosity, hypercholesterolemia as well as related immune issues)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The areas of low - intensity laser use have expanded in several conditions by different
      mechanisms and ways. Hypertension as one of coronary artery disease risk factors and early
      indicator of future cardiovascular events with high blood viscosity and elevated blood
      cholesterol levels with immune-pathological basis became necessary issue to be handled. Low
      Level Laser irradiation effects on blood is very essential way in revealing the mechanisms of
      the action of laser radiation on biological tissues by means of changes in metabolism,
      leading to molecular, cellular and systemic changes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">December 30, 2018</completion_date>
  <primary_completion_date type="Actual">August 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of blood pressure</measure>
    <time_frame>8 weeks</time_frame>
    <description>measuring blood pressure before and after each low level laser radiation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in blood viscosity</measure>
    <time_frame>8 weeks</time_frame>
    <description>measuring changes in blood viscosity before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in IL-17 level</measure>
    <time_frame>45 days</time_frame>
    <description>measuring changes in IL-17 level before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in functional capacity</measure>
    <time_frame>70 days</time_frame>
    <description>measuring of 6 minute walking test before and after low level laser irradiation as an indicator of functional capacity improving</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in CD 8 (cluster of differentiation 8) level</measure>
    <time_frame>45 days</time_frame>
    <description>measuring changes in CD 8 (cluster of differentiation 8) level before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in TC (total cholesterol) level</measure>
    <time_frame>60 days</time_frame>
    <description>measuring changes in TC (total cholesterol) level before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in LDL (low density lipoprotien) level</measure>
    <time_frame>60 days</time_frame>
    <description>measuring changes in LDL (low density lipoprotien) level before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in TG (triglyceride) level</measure>
    <time_frame>60 days</time_frame>
    <description>measuring changes in TG (triglyceride) level before and after low level laser radiation session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in HDL (high density lipoprotien) level</measure>
    <time_frame>60 days</time_frame>
    <description>measuring changes in HDL (high density lipoprotien) level before and after low level laser radiation session</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>low level laser hemotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Watch laser acupuncture and nasal irradiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>all the participants in this group did not receive low level laser irradiation during the study period</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>low level laser hemotherapy</intervention_name>
    <description>semiconductor laser therapeutic instrument irradiate the circulating blood in the vessels of left hand acupoint and the mucosal tissue in the nasal cavity</description>
    <arm_group_label>low level laser hemotherapy</arm_group_label>
    <other_name>Watch laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stage I hypertensive patients

          -  patients from 30 to 34.9 kg/m2 body mass index

          -  medically stable patients

          -  all participants have sufficient cognition enough to understand the requirements of
             the study

        Exclusion Criteria:

          -  history of malignant disease

          -  smoking

          -  history of progressive fatal disease

          -  history of drug or alcohol abuse

          -  blood donation within at least 30 days

          -  pregnant, trying to be pregnant or breast feeding

          -  cognitive impairment that will make it difficult to partake in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cairo Giza, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo</name>
      <address>
        <city>Giza</city>
        <state>Dokki</state>
        <zip>11432</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 6, 2018</study_first_posted>
  <last_update_submitted>February 5, 2019</last_update_submitted>
  <last_update_submitted_qc>February 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ebtesam Nabil</investigator_full_name>
    <investigator_title>lecturer assistance at Cairo University</investigator_title>
  </responsible_party>
  <keyword>hypertension</keyword>
  <keyword>high blood viscosity</keyword>
  <keyword>hypercholesterolemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified participated data for underlie results reported in this trial</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>data will be available after 6 months of study completion and ending 36 months</ipd_time_frame>
    <ipd_access_criteria>proposals should directed to Dr.EbtesamNagy@cu.edu.eg. To gain access, data requestors will need to sign a data access agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

